Literature DB >> 26986047

Nonthermal Ablation by Using Intravascular Oxygen Radical Generation with WST11: Dynamic Tissue Effects and Implications for Focal Therapy.

Simon Y Kimm1, Tatum V Tarin1, Sébastien Monette1, Govindarajan Srimathveeravalli1, Daniel Gerber1, Jeremy C Durack1, Stephen B Solomon1, Peter T Scardino1, Avigdor Scherz1, Jonathan Coleman1.   

Abstract

Purpose To examine the hypothesis that vascular-targeted photodynamic therapy (VTP) with WST11 and clinically relevant parameters can be used to ablate target tissues in a non-tumor-bearing large-animal model while selectively sparing blood vessels and collagen. Materials and Methods By using an institutional animal care and use committee-approved protocol, 68 ablations were performed in the kidneys (cortex and medulla) and livers of 27 adult pigs. Posttreatment evaluation was conducted with contrast material-enhanced computed tomography in the live animals at 24 hours. Immunohistochemistry was evaluated and histologic examination with hematoxylin-eosin staining was performed at 4 hours, 24 hours, and 7 days. Intravenous infusion of WST11 (4 mg per kilogram of body weight) was followed by using near-infrared illumination (753 nm for 20 minutes) through optical fibers prepositioned in target tissues by using a fixed template. Treated areas were scanned, measured, and statistically analyzed by using the Student t test and two-way analysis of variance. Results Focal WST11 VTP treatment in the liver and kidney by using a single optical fiber resulted in well-demarcated cylindrical zones of nonthermal necrosis concentrically oriented around the light-emitting diffuser, with no intervening viable parenchymal cells. The radius of ablated tissue increased from approximately 5 mm at 150 mW to approximately 7 mm at 415 mW (P < .01). Illumination through fiber triads at 1-cm separation resulted in confluent homogeneous necrosis. Patterns of acute injury within 24 hours were consistent with microcirculatory flow arrest and collagen preservation (demonstrated with trichrome staining). In the peripheral ablation zone, blood vessels at least 40 μm in diameter were selectively preserved and remained functional at 7 days. Ablated tissues exhibited progressive fibrosis and chronic inflammatory cell infiltrates. No histologic changes consistent with thermal injury were observed in blood vessels or collagen. The renal hilum and collecting system did not show treatment effect, despite treatment proximity. Conclusion WST11 VTP induces nonthermal tissue ablation in target tissue while preserving critical organ structures and bystander blood vessels within solid organs. (©) RSNA, 2016 Online supplemental material is available for this article.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26986047      PMCID: PMC5047127          DOI: 10.1148/radiol.2016141571

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  37 in total

Review 1.  Principles of and advances in percutaneous ablation.

Authors:  Muneeb Ahmed; Christopher L Brace; Fred T Lee; S Nahum Goldberg
Journal:  Radiology       Date:  2011-02       Impact factor: 11.105

2.  Radiofrequency versus microwave ablation in a hepatic porcine model.

Authors:  Andrew S Wright; Lisa A Sampson; Thomas F Warner; David M Mahvi; Fred T Lee
Journal:  Radiology       Date:  2005-07       Impact factor: 11.105

Review 3.  New insights into the mechanisms for photodynamic therapy-induced cancer cell death.

Authors:  Je-Ok Yoo; Kwon-Soo Ha
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 4.  Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion.

Authors:  Kate Ross; Basil Cherpelis; Mary Lien; Neil Fenske
Journal:  Dermatol Surg       Date:  2013-10-09       Impact factor: 3.398

5.  Efficiency function: improvement of classical bioheat approach.

Authors:  H Brinck; J Werner
Journal:  J Appl Physiol (1985)       Date:  1994-10

6.  Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee.

Authors:  Lincoln L Berland; Stuart G Silverman; Richard M Gore; William W Mayo-Smith; Alec J Megibow; Judy Yee; James A Brink; Mark E Baker; Michael P Federle; W Dennis Foley; Isaac R Francis; Brian R Herts; Gary M Israel; Glenn Krinsky; Joel F Platt; William P Shuman; Andrew J Taylor
Journal:  J Am Coll Radiol       Date:  2010-10       Impact factor: 5.532

7.  Feasibility of nerve-sparing prostate cryosurgery: applications and limitations in a canine model.

Authors:  Nicolette K Janzen; Ken-Ryu Han; Kent T Perry; Jonathan W Said; Peter G Schulam; Arie S Belldegrun
Journal:  J Endourol       Date:  2005-05       Impact factor: 2.942

Review 8.  High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer.

Authors:  Ernesto R Cordeiro; Xavier Cathelineau; Stefan Thüroff; Michael Marberger; Sebastien Crouzet; Jean J M C H de la Rosette
Journal:  BJU Int       Date:  2012-06-06       Impact factor: 5.588

9.  Systemic antitumor protection by vascular-targeted photodynamic therapy involves cellular and humoral immunity.

Authors:  Dina Preise; Roni Oren; Itai Glinert; Vyacheslav Kalchenko; Steffen Jung; Avigdor Scherz; Yoram Salomon
Journal:  Cancer Immunol Immunother       Date:  2008-05-17       Impact factor: 6.968

Review 10.  Photodynamic therapy of cancer. Basic principles and applications.

Authors:  Angeles Juarranz; Pedro Jaén; Francisco Sanz-Rodríguez; Jesús Cuevas; Salvador González
Journal:  Clin Transl Oncol       Date:  2008-03       Impact factor: 3.405

View more
  13 in total

1.  In Vivo Imaging With Confirmation by Histopathology for Increased Rigor and Reproducibility in Translational Research: A Review of Examples, Options, and Resources.

Authors:  Kathleen Gabrielson; Robert Maronpot; Sébastien Monette; Coraline Mlynarczyk; Yuval Ramot; Abraham Nyska; Polina Sysa-Shah
Journal:  ILAR J       Date:  2018-12-01

2.  Bombesin Antagonist-Based Radiotherapy of Prostate Cancer Combined with WST-11 Vascular Targeted Photodynamic Therapy.

Authors:  Kwanghee Kim; Hanwen Zhang; Stephen La Rosa; Sylvia Jebiwott; Pooja Desai; Simon Kimm; Avigdor Scherz; Joseph A O'Donoghue; Wolfgang A Weber; Jonathan A Coleman
Journal:  Clin Cancer Res       Date:  2017-01-20       Impact factor: 12.531

3.  Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.

Authors:  Katie S Murray; Ashley G Winter; Renato Beluco Corradi; Stephen LaRosa; Sylvia Jebiwott; Alexander Somma; Haruyuki Takaki; Govindarajan Srimathveeravalli; Michelle Lepherd; Sebastien Monette; Kwanghee Kim; Avigdor Scherz; Jonathan A Coleman
Journal:  J Urol       Date:  2016-02-06       Impact factor: 7.450

Review 4.  Contemporary treatments in prostate cancer focal therapy.

Authors:  Michael Ahdoot; Amir H Lebastchi; Baris Turkbey; Bradford Wood; Peter A Pinto
Journal:  Curr Opin Oncol       Date:  2019-05       Impact factor: 3.645

Review 5.  Focal prostate cancer therapy in the era of multiparametric MRI: a review of options and outcomes.

Authors:  John R Heard; Aurash Naser-Tavakolian; Michael Nazmifar; Michael Ahdoot
Journal:  Prostate Cancer Prostatic Dis       Date:  2022-03-04       Impact factor: 5.455

6.  Contrast enhanced ultrasound imaging can predict vascular-targeted photodynamic therapy induced tumor necrosis in small animals.

Authors:  F H Cornelis; K Kim; J C Durack; S Jebiwott; A Scherz; G Srimathveeravalli; J A Coleman
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-09-05       Impact factor: 3.631

7.  Randomized Trial of Partial Gland Ablation with Vascular Targeted Phototherapy versus Active Surveillance for Low Risk Prostate Cancer: Extended Followup and Analyses of Effectiveness.

Authors:  Inderbir S Gill; Abdel-Rahmene Azzouzi; Mark Emberton; Jonathan A Coleman; Emmanuel Coeytaux; Avigdor Scherz; Peter T Scardino
Journal:  J Urol       Date:  2018-06-02       Impact factor: 7.450

8.  Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.

Authors:  Ricardo Alvim; Karan Nagar; Sudeep Das; Souhil Lebdai; Nathan Wong; Alexander Somma; Christopher Hughes; Jasmine Thomas; Sébastien Monette; Avigdor Scherz; Kwanghee Kim; Jan Grimm; Jonathan A Coleman
Journal:  Eur Urol Focus       Date:  2019-06-18

9.  Detection of Treatment Success after Photodynamic Therapy Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging.

Authors:  Tom J L Schreurs; Igor Jacobs; Klaas Nicolay; Jeanine J Prompers; Gustav J Strijkers
Journal:  Theranostics       Date:  2017-10-17       Impact factor: 11.556

10.  WST11 Vascular Targeted Photodynamic Therapy Effect Monitoring by Multispectral Optoacoustic Tomography (MSOT) in Mice.

Authors:  Volker Neuschmelting; Kwanghee Kim; Jaber Malekzadeh-Najafabadi; Sylvia Jebiwott; Jaya Prakash; Avigdor Scherz; Jonathan A Coleman; Moritz F Kircher; Vasilis Ntziachristos
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.